Jump to main content
Jump to site search

Issue 42, 2016
Previous Article Next Article

Tumor therapy: targeted drug delivery systems

Author affiliations

Abstract

Recently, targeted drug delivery systems (TDDSs) have been extensively studied as a promising therapeutic for tumor therapy. In this review, we investigate the typical targeting mechanisms of TDDSs, covering both passively and actively targeting DDSs for tumor therapy. We highlight the popular active targeting strategies for different sites of action, including tumor cytomembrane or various organelles. Finally, we present some recent representative TDDSs that are under testing in preclinical/clinical trials and have shown excellent clinical potential as the alternate treatment strategy for tumor therapy. Although TDDSs are proving to be promising therapeutic nanoplatforms for tumor therapy, extended investigations should be considered in the landscape for highly efficient tumor therapy with good biosafety.

Graphical abstract: Tumor therapy: targeted drug delivery systems

Back to tab navigation

Publication details

The article was received on 12 Jul 2016, accepted on 26 Aug 2016 and first published on 26 Aug 2016


Article type: Review Article
DOI: 10.1039/C6TB01743F
Citation: J. Mater. Chem. B, 2016,4, 6758-6772
  •   Request permissions

    Tumor therapy: targeted drug delivery systems

    L. Dai, J. Liu, Z. Luo, M. Li and K. Cai, J. Mater. Chem. B, 2016, 4, 6758
    DOI: 10.1039/C6TB01743F

Search articles by author

Spotlight

Advertisements